| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/107327481101800102 |
| P698 | PubMed publication ID | 21273975 |
| P2093 | author name string | Johnathan M Lancaster | |
| Hye Sook Chon | |||
| P2860 | cites work | Overexpression of kallikrein 10 in epithelial ovarian carcinomas | Q44487914 |
| Influence of surgery and postoperative therapy and tumor characteristics on patient prognosis in advanced ovarian carcinomas | Q44641810 | ||
| Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma | Q46849137 | ||
| Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer | Q47896747 | ||
| Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors. | Q50613227 | ||
| Prediction of chemotherapeutic response in ovarian cancer with DNA microarray expression profiling. | Q50992026 | ||
| An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma. | Q51924460 | ||
| Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. | Q53609842 | ||
| Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. | Q53856733 | ||
| Unique gene expression profile based on pathologic response in epithelial ovarian cancer. | Q53993369 | ||
| Light-generated oligonucleotide arrays for rapid DNA sequence analysis | Q24563041 | ||
| The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements | Q24597089 | ||
| Identification of interferon-modulated proliferation-related cDNA sequences | Q24632292 | ||
| Gene expression patterns in ovarian carcinomas | Q24644996 | ||
| Yeast microarrays for genome wide parallel genetic and gene expression analysis | Q24657389 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Minimum information about a microarray experiment (MIAME)-toward standards for microarray data | Q27860569 | ||
| Molecular classification of cancer: class discovery and class prediction by gene expression monitoring | Q27861072 | ||
| Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker | Q31135269 | ||
| Molecular profiling of platinum resistant ovarian cancer. | Q33227163 | ||
| Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome | Q33359495 | ||
| Serum protein markers for early detection of ovarian cancer | Q33836343 | ||
| Gene expression in fixed tissues and outcome in hepatocellular carcinoma. | Q34235518 | ||
| Recent advances in the treatment of epithelial ovarian cancer | Q34481727 | ||
| Genomic signatures to guide the use of chemotherapeutics. | Q34576027 | ||
| Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome | Q34632529 | ||
| Ovarian cancer: progress and continuing controversies in management | Q34783604 | ||
| Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles | Q35746921 | ||
| Diverse tumorigenic pathways in ovarian serous carcinoma | Q35789009 | ||
| Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells | Q36616527 | ||
| Fabrication of DNA microarray. | Q37453216 | ||
| A novel, high-performance random array platform for quantitative gene expression profiling | Q37600602 | ||
| Gene expression patterns that characterize advanced stage serous ovarian cancers | Q38346270 | ||
| Osteopontin as a potential diagnostic biomarker for ovarian cancer | Q38457189 | ||
| An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. | Q40172885 | ||
| Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers | Q40391221 | ||
| Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling | Q40444417 | ||
| Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology | Q43754824 | ||
| P433 | issue | 1 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 8-15 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Cancer Control | Q15724614 |
| P1476 | title | Microarray-based gene expression studies in ovarian cancer | |
| P478 | volume | 18 |
| Q92629419 | A Nutrigenomics Approach Using RNA Sequencing Technology to Study Nutrient-Gene Interactions in Agricultural Animals |
| Q37720579 | Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortium |
| Q38465175 | An integrated analysis of the effects of microRNA and mRNA on esophageal squamous cell carcinoma |
| Q38087982 | Biomarkers for early detection of ovarian cancer |
| Q37507405 | Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer. |
| Q26859166 | Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer |
| Q37522638 | Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study |
| Q36380325 | High-prevalence and broad spectrum of Cell Adhesion and Extracellular Matrix gene pathway mutations in epithelial ovarian cancer |
| Q30783271 | How to get the most from microarray data: advice from reverse genomics |
| Q59811500 | Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer |
| Q35764376 | Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients |
| Q35628524 | Integrated microRNA-mRNA analysis revealing the potential roles of microRNAs in tongue squamous cell cancer |
| Q30882404 | Integrative network analysis of TCGA data for ovarian cancer |
| Q30775752 | MAAMD: a workflow to standardize meta-analyses and comparison of affymetrix microarray data |
| Q33977915 | Next-generation sequencing and microarray-based interrogation of microRNAs from formalin-fixed, paraffin-embedded tissue: preliminary assessment of cross-platform concordance |
| Q35837949 | Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways |
| Q89304970 | RNA Sequencing of Carboplatin- and Paclitaxel-Resistant Endometrial Cancer Cells Reveals New Stratification Markers and Molecular Targets for Cancer Treatment |
| Q30584281 | StRAP: an integrated resource for profiling high-throughput cancer genomic data from stress response studies |
| Q34243648 | Transcriptional profiling of formalin fixed paraffin embedded tissue: pitfalls and recommendations for identifying biologically relevant changes |
| Q61853673 | Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium |
| Q34431079 | ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival |
Search more.